Aspen Aerogels, Inc. (NYSE:ASPN) Given Consensus Rating of “Hold” by Brokerages

Shares of Aspen Aerogels, Inc. (NYSE:ASPNGet Free Report) have earned a consensus recommendation of “Hold” from the six analysts that are covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $5.1875.

A number of analysts have commented on the stock. Wall Street Zen raised shares of Aspen Aerogels from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Aspen Aerogels in a research report on Wednesday, June 24th. Roth Capital reaffirmed a “buy” rating and issued a $5.75 price target on shares of Aspen Aerogels in a research report on Friday, May 8th. Finally, Barclays boosted their price objective on shares of Aspen Aerogels from $3.00 to $4.00 and gave the stock an “underweight” rating in a report on Monday, May 11th.

Get Our Latest Research Report on ASPN

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Invesco Ltd. increased its position in Aspen Aerogels by 237.9% in the fourth quarter. Invesco Ltd. now owns 4,129,934 shares of the construction company’s stock worth $11,688,000 after purchasing an additional 2,907,558 shares during the period. Needham Investment Management LLC boosted its position in shares of Aspen Aerogels by 26.5% during the fourth quarter. Needham Investment Management LLC now owns 4,351,700 shares of the construction company’s stock worth $12,315,000 after purchasing an additional 912,000 shares in the last quarter. JPMorgan Chase & Co. grew its stake in Aspen Aerogels by 105.4% in the second quarter. JPMorgan Chase & Co. now owns 1,246,506 shares of the construction company’s stock valued at $7,379,000 after acquiring an additional 639,753 shares during the period. Goldman Sachs Group Inc. grew its position in shares of Aspen Aerogels by 89.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,274,356 shares of the construction company’s stock valued at $8,143,000 after purchasing an additional 602,586 shares during the period. Finally, State Street Corp increased its position in shares of Aspen Aerogels by 28.6% during the fourth quarter. State Street Corp now owns 2,501,469 shares of the construction company’s stock worth $7,079,000 after acquiring an additional 556,833 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Aspen Aerogels Price Performance

NYSE ASPN opened at $5.15 on Friday. Aspen Aerogels has a 12 month low of $2.30 and a 12 month high of $9.78. The firm has a market capitalization of $427.15 million, a PE ratio of -3.79 and a beta of 2.98. The company’s 50 day simple moving average is $5.68 and its 200 day simple moving average is $4.31. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.89 and a quick ratio of 2.54.

Aspen Aerogels (NYSE:ASPNGet Free Report) last announced its quarterly earnings data on Thursday, May 7th. The construction company reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.27) by ($0.01). Aspen Aerogels had a negative net margin of 48.64% and a negative return on equity of 22.16%. The firm had revenue of $37.88 million during the quarter, compared to analyst estimates of $36.58 million. During the same quarter last year, the company earned ($0.06) EPS. The company’s quarterly revenue was down 51.8% compared to the same quarter last year. Aspen Aerogels has set its Q2 2026 guidance at -0.240–0.17 EPS. As a group, equities research analysts forecast that Aspen Aerogels will post -0.8 EPS for the current fiscal year.

About Aspen Aerogels

(Get Free Report)

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.

See Also

Analyst Recommendations for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.